{
    "root": "fe0f7f8e-5ddc-4285-ab81-52caf6deffcd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "CARDENE IV",
    "value": "20250221",
    "ingredients": [
        {
            "name": "NICARDIPINE HYDROCHLORIDE",
            "code": "K5BC5011K3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7551"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31404"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "\u2022 cardene i.v . calcium channel blocker indicated short-term treatment hypertension oral therapy feasible . ( 1.1 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 intravenous . ( 2.1 ) \u2022 dilution required . ( 2.3 ) \u2022 substituting oral nicardipine therapy , intravenous infusion rate table ( 2.1 ) : oral cardene dose equivalent i.v . infusion rate ( 0.1 mg/ml ) equivalent i.v . infusion rate ( 0.2 mg/ml ) 20 mg q8h 0.5 mg/hr = 5 ml/hr 0.5 mg/hr = 2.5 ml/hr 30 mg q8h 1.2 mg/hr = 12 ml/hr 1.2 mg/hr = 6 ml/hr 40 mg q8h 2.2 mg/hr = 22 ml/hr 2.2 mg/hr = 11 ml/hr \u2022 patient receiving oral nicardipine , initiate therapy 5 mg/hr . increase infusion rate 2.5 mg/hr every 5 minutes ( rapid titration ) 15 minutes ( gradual titration ) maximum 15 mg/hr desired blood pressure reduction achieved . ( 2.1 ) conversion table ( mg/hr ) equivalent i.v . infusion rate ( 0.1 mg/ml ) equivalent i.v . infusion rate ( 0.2 mg/ml ) 5 mg/hr 50 ml/hr 25 ml/hr 2.5 mg/hr 25 ml/hr 12.5 ml/hr 15 mg/hr 150 ml/hr 75 ml/hr \u2022 unacceptable hypotension tachycardia occurs , discontinue infusion . blood pressure heart rate stabilize , restart infusion low doses 3-5 mg/hr . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "\u2022 patients advanced aortic stenosis ( 4.1 ) .",
    "indications_original": "\u2022 CARDENE I.V. is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. ( 1.1 )",
    "contraindications_original": "\u2022 For Intravenous Use. ( 2.1 ) \u2022 No further dilution is required. ( 2.3 ) \u2022 When substituting for oral nicardipine therapy, use the intravenous infusion rate from the table below ( 2.1 ): Oral CARDENE Dose Equivalent I.V. Infusion Rate (0.1 mg/mL) Equivalent I.V. Infusion Rate (0.2 mg/mL) 20 mg q8h 0.5 mg/hr = 5 mL/hr 0.5 mg/hr = 2.5 mL/hr 30 mg q8h 1.2 mg/hr = 12 mL/hr 1.2 mg/hr = 6 mL/hr 40 mg q8h 2.2 mg/hr = 22 mL/hr 2.2 mg/hr = 11 mL/hr \u2022 In a patient not receiving oral nicardipine, initiate therapy at 5 mg/hr. Increase the infusion rate by 2.5 mg/hr every 5 minutes (for rapid titration) to 15 minutes (for gradual titration) up to a maximum of 15 mg/hr until desired blood pressure reduction is achieved. ( 2.1 ) Conversion Table (mg/hr) Equivalent I.V. Infusion Rate (0.1 mg/mL) Equivalent I.V. Infusion Rate (0.2 mg/mL) 5 mg/hr 50 mL/hr 25 mL/hr 2.5 mg/hr 25 mL/hr 12.5 mL/hr 15 mg/hr 150 mL/hr 75 mL/hr \u2022 If unacceptable hypotension or tachycardia occurs, discontinue the infusion. When blood pressure and heart rate stabilize, restart the infusion at low doses such as 3-5 mg/hr. ( 2.2 )",
    "adverseReactions_original": "\u2022 Do not use in patients with advanced aortic stenosis ( 4.1 ).",
    "drug": [
        {
            "name": "CARDENE IV",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7551"
        }
    ]
}